Patricia E. Greenstein, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Galactosemias | 2 | 2020 | 124 | 0.750 |
Why?
|
| Neurites | 1 | 2020 | 391 | 0.610 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2020 | 2790 | 0.310 |
Why?
|
| Dementia | 1 | 2020 | 2686 | 0.250 |
Why?
|
| Brain Mapping | 2 | 2020 | 6630 | 0.240 |
Why?
|
| Machado-Joseph Disease | 2 | 2012 | 26 | 0.240 |
Why?
|
| Interferon-beta | 1 | 2006 | 345 | 0.220 |
Why?
|
| Vision, Monocular | 1 | 2023 | 71 | 0.210 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2004 | 247 | 0.210 |
Why?
|
| Retinal Artery Occlusion | 1 | 2023 | 77 | 0.210 |
Why?
|
| Tick Paralysis | 1 | 2002 | 2 | 0.210 |
Why?
|
| Adjuvants, Immunologic | 1 | 2006 | 1036 | 0.170 |
Why?
|
| Transverse Sinuses | 1 | 2019 | 25 | 0.160 |
Why?
|
| Alzheimer Disease | 1 | 2020 | 8599 | 0.150 |
Why?
|
| Huntington Disease | 1 | 2004 | 1144 | 0.150 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2019 | 140 | 0.150 |
Why?
|
| Myotonic Dystrophy | 1 | 1997 | 78 | 0.140 |
Why?
|
| Liver Diseases | 1 | 2006 | 1298 | 0.140 |
Why?
|
| Spinocerebellar Degenerations | 1 | 1996 | 44 | 0.140 |
Why?
|
| Anisotropy | 1 | 2020 | 1283 | 0.140 |
Why?
|
| Cerebellar Diseases | 1 | 2018 | 220 | 0.130 |
Why?
|
| Ataxia | 1 | 2018 | 306 | 0.130 |
Why?
|
| Muscular Diseases | 1 | 2019 | 553 | 0.120 |
Why?
|
| Mosaicism | 1 | 1997 | 475 | 0.110 |
Why?
|
| Catheterization | 1 | 2019 | 1428 | 0.110 |
Why?
|
| Motor Activity | 2 | 2020 | 2715 | 0.100 |
Why?
|
| Cerebellar Ataxia | 1 | 2013 | 150 | 0.100 |
Why?
|
| Dexamethasone | 1 | 2019 | 1948 | 0.100 |
Why?
|
| Language | 1 | 2020 | 1540 | 0.090 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2019 | 1520 | 0.090 |
Why?
|
| Multiple Sclerosis | 1 | 2006 | 3220 | 0.090 |
Why?
|
| Nicotinic Agonists | 1 | 2012 | 265 | 0.090 |
Why?
|
| Quinoxalines | 1 | 2012 | 296 | 0.090 |
Why?
|
| Benzazepines | 1 | 2012 | 310 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2019 | 2161 | 0.080 |
Why?
|
| Cerebral Arteries | 1 | 2011 | 490 | 0.080 |
Why?
|
| Neuropsychological Tests | 2 | 2020 | 7045 | 0.070 |
Why?
|
| Muscle, Skeletal | 2 | 2019 | 4948 | 0.070 |
Why?
|
| Cerebellum | 1 | 2013 | 1501 | 0.070 |
Why?
|
| Endovascular Procedures | 1 | 2019 | 2183 | 0.060 |
Why?
|
| Electroencephalography | 1 | 2020 | 6225 | 0.060 |
Why?
|
| Liver Function Tests | 1 | 2006 | 523 | 0.060 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2013 | 1472 | 0.060 |
Why?
|
| Dermacentor | 1 | 2002 | 1 | 0.050 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2004 | 783 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2020 | 22176 | 0.050 |
Why?
|
| Myoglobinuria | 1 | 2000 | 22 | 0.050 |
Why?
|
| Prednisone | 1 | 2006 | 1563 | 0.050 |
Why?
|
| North America | 1 | 2004 | 1276 | 0.050 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2011 | 1405 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 1626 | 0.040 |
Why?
|
| Japan | 1 | 2004 | 1378 | 0.040 |
Why?
|
| Electron Transport Complex IV | 1 | 2000 | 190 | 0.040 |
Why?
|
| Adult | 9 | 2020 | 221177 | 0.040 |
Why?
|
| Acetylcholine | 1 | 2002 | 629 | 0.040 |
Why?
|
| Genotype | 3 | 2011 | 12990 | 0.040 |
Why?
|
| Blindness | 1 | 2023 | 584 | 0.040 |
Why?
|
| Humans | 17 | 2023 | 761504 | 0.040 |
Why?
|
| Male | 9 | 2020 | 360804 | 0.040 |
Why?
|
| Female | 12 | 2023 | 392644 | 0.040 |
Why?
|
| Embryonic Induction | 2 | 1995 | 151 | 0.040 |
Why?
|
| Fluorescein Angiography | 1 | 2023 | 1059 | 0.040 |
Why?
|
| Age of Onset | 1 | 2004 | 3305 | 0.040 |
Why?
|
| Gait | 2 | 2013 | 814 | 0.040 |
Why?
|
| Pedigree | 1 | 2004 | 4542 | 0.030 |
Why?
|
| Trinucleotide Repeats | 1 | 1997 | 257 | 0.030 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1997 | 217 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 59243 | 0.030 |
Why?
|
| Mesoderm | 2 | 1995 | 674 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2000 | 865 | 0.030 |
Why?
|
| Aged | 5 | 2023 | 169289 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2006 | 11076 | 0.030 |
Why?
|
| Catalepsy | 1 | 1993 | 31 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 1997 | 1834 | 0.030 |
Why?
|
| Acute Disease | 1 | 2023 | 7237 | 0.030 |
Why?
|
| Retina | 1 | 2023 | 2659 | 0.030 |
Why?
|
| Zebrafish Proteins | 2 | 1995 | 1014 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 12974 | 0.020 |
Why?
|
| UTP-Hexose-1-Phosphate Uridylyltransferase | 1 | 2011 | 68 | 0.020 |
Why?
|
| Dominance, Cerebral | 1 | 1993 | 623 | 0.020 |
Why?
|
| Eye | 1 | 1995 | 712 | 0.020 |
Why?
|
| Protein Kinases | 1 | 1997 | 1608 | 0.020 |
Why?
|
| Proteins | 2 | 1995 | 6032 | 0.020 |
Why?
|
| Central Nervous System | 1 | 1997 | 1336 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2023 | 2917 | 0.020 |
Why?
|
| Liver | 1 | 2006 | 7529 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 763 | 0.020 |
Why?
|
| Stroke | 1 | 2011 | 9757 | 0.020 |
Why?
|
| Electromyography | 1 | 2013 | 1394 | 0.020 |
Why?
|
| Phenotype | 3 | 2011 | 16591 | 0.020 |
Why?
|
| Cerebral Infarction | 1 | 1993 | 983 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 15842 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2004 | 7856 | 0.020 |
Why?
|
| Middle Aged | 6 | 2019 | 220895 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2013 | 64680 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1997 | 1909 | 0.020 |
Why?
|
| Zebrafish | 2 | 1995 | 3007 | 0.020 |
Why?
|
| Neonatal Screening | 1 | 2011 | 597 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 1995 | 1699 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2019 | 5972 | 0.020 |
Why?
|
| Trans-Activators | 1 | 1995 | 2856 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2011 | 26198 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2006 | 23995 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 39106 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1995 | 3612 | 0.010 |
Why?
|
| Affect | 1 | 2012 | 1486 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 58976 | 0.010 |
Why?
|
| Neurodegenerative Diseases | 1 | 2011 | 1087 | 0.010 |
Why?
|
| DNA Primers | 2 | 1995 | 2819 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2000 | 767 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 9031 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2012 | 12341 | 0.010 |
Why?
|
| Mutation | 1 | 2000 | 30052 | 0.010 |
Why?
|
| Notochord | 1 | 1995 | 37 | 0.010 |
Why?
|
| Muscles | 1 | 2000 | 1576 | 0.010 |
Why?
|
| Disease Progression | 1 | 2011 | 13506 | 0.010 |
Why?
|
| Base Sequence | 2 | 1995 | 12441 | 0.010 |
Why?
|
| Animals | 3 | 2002 | 168459 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1995 | 13446 | 0.010 |
Why?
|
| Xenopus | 1 | 1995 | 711 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1995 | 17635 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 9280 | 0.010 |
Why?
|
| Brain Damage, Chronic | 1 | 1993 | 267 | 0.010 |
Why?
|
| Caudate Nucleus | 1 | 1993 | 389 | 0.010 |
Why?
|
| Morphogenesis | 1 | 1995 | 741 | 0.010 |
Why?
|
| Hemianopsia | 1 | 1993 | 121 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1995 | 1900 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 1995 | 718 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 2748 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1995 | 2180 | 0.010 |
Why?
|
| Hedgehog Proteins | 1 | 1995 | 768 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1993 | 916 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 1995 | 1342 | 0.010 |
Why?
|
| Posture | 1 | 1993 | 957 | 0.000 |
Why?
|
| Brain | 1 | 1995 | 27112 | 0.000 |
Why?
|
| Recurrence | 1 | 2000 | 8465 | 0.000 |
Why?
|
| Drosophila | 1 | 1995 | 1495 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 13639 | 0.000 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 6075 | 0.000 |
Why?
|
| Adolescent | 1 | 2011 | 88319 | 0.000 |
Why?
|
| Gene Expression | 1 | 1995 | 7581 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 1993 | 5777 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1993 | 36426 | 0.000 |
Why?
|